| |
| |
|
| Insider
Information: |
Noyes Timothy P |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protara Therapeutics, Inc |
TARA |
President and CEO, Dir... |
2018-02-16 |
0 |
2015-09-08 |
0 |
Premium* |
|
|
Aerovate Therapeutics, Inc. |
AVTE |
|
2024-05-16 |
0 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-09-08 |
4 |
OE |
$1.91 |
$9,550 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-09-08 |
4 |
AS |
$13.55 |
$67,750 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-10-01 |
4 |
OE |
$1.91 |
$9,550 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-10-01 |
4 |
AS |
$13.33 |
$66,650 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-11-02 |
4 |
OE |
$1.91 |
$9,550 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-11-02 |
4 |
AS |
$13.50 |
$67,500 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-12-01 |
4 |
AS |
$14.97 |
$74,850 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2015-12-01 |
4 |
OE |
$1.91 |
$9,550 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2016-01-04 |
4 |
OE |
$1.91 |
$9,550 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2016-01-04 |
4 |
AS |
$13.88 |
$69,400 |
D/D |
(5,000) |
0 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2016-04-12 |
4 |
OE |
$1.91 |
$112,197 |
D/D |
58,742 |
58,742 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2017-09-14 |
4 |
D |
$1.45 |
$7,058 |
D/D |
(4,854) |
53,888 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2017-09-15 |
4 |
D |
$1.48 |
$7,611 |
D/D |
(5,146) |
48,742 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2017-10-16 |
4 |
D |
$2.31 |
$23,120 |
D/D |
(10,000) |
38,742 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2017-11-14 |
4 |
D |
$1.69 |
$7,338 |
D/D |
(4,350) |
34,392 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2017-11-15 |
4 |
D |
$1.70 |
$9,616 |
D/D |
(5,650) |
28,742 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2017-12-14 |
4 |
D |
$1.85 |
$18,540 |
D/D |
(10,000) |
18,742 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2018-01-16 |
4 |
D |
$2.36 |
$23,570 |
D/D |
(10,000) |
8,742 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2018-02-14 |
4 |
D |
$2.20 |
$7,700 |
D/D |
(3,500) |
5,242 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2018-02-15 |
4 |
D |
$2.15 |
$4,831 |
D/D |
(2,245) |
2,997 |
0 |
- |
|
| TARA |
Protara Therapeutics, Inc |
President and CEO |
• • – |
2018-02-16 |
4 |
D |
$2.11 |
$6,324 |
D/D |
(2,997) |
0 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-11-01 |
4 |
AS |
$19.50 |
$20,241 |
D/D |
(1,038) |
0 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-12-01 |
4 |
OE |
$2.14 |
$32,100 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-12-01 |
4 |
AS |
$18.00 |
$270,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-03 |
4 |
AS |
$26.80 |
$406,076 |
D/D |
(15,000) |
0 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
